Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
Mohammad-Reza Sedghipour, Ali Mostafaei, Yousef TaghaviNikoukari Ophthalmology University Hospital, Tabriz University of Medical Sciences, Tabriz, IranBackground: The purpose of this study was to assess the effect of bevacizumab in maintaining intraocular pressure lowered by trabeculectomy in refrac...
Saved in:
Main Authors: | Sedghipour MR, Mostafaei A, Taghavi Y |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/fa3dea984b954836aa23f9eb47322a3d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
by: Mostafaei A
Published: (2011) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
by: Saeed AM, et al.
Published: (2014) -
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
by: Freiberg FJ, et al.
Published: (2013) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
by: Marey HM, et al.
Published: (2011) -
Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma
by: Christopher C Shen, et al.
Published: (2011)